数字医疗系统能否提高抗精神病药物治疗的依从性？
Can a digital medicine system improve adherence to antipsychotic treatment?
机构信息
Department of Neuroscience,Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona,Verona,Italy.
出版信息
Epidemiol Psychiatr Sci. 2018 Jun;27(3):227-229. doi: 10.1017/S2045796018000082. Epub 2018 Mar 12.
Abstract
A substantial proportion of people with mental health conditions do not adhere to prescribed pharmacological treatments. Poor adherence is probably one of the most critical elements contributing to relapse in people with schizophrenia and other severe mental disorders. In order to tackle this global issue, in November 2017 the Food and Drug Administration approved a tablet formulation of the atypical antipsychotic aripiprazole embedded with a novel digital adherence-assessment device. In this commentary, we critically appraised the potential beneficial and harmful consequences of this new digital formulation of aripiprazole, and we highlighted expected implications for clinical practice.
摘要
相当一部分患有精神健康问题的人不遵守规定的药物治疗方案。治疗依从性差可能是导致精神分裂症和其他严重精神障碍患者病情复发的最重要因素之一。为了解决这个全球性问题，食品和药物管理局于 2017 年 11 月批准了一种将新型数字药物依从性评估装置嵌入其中的非典型抗精神病药阿立哌唑的片剂制剂。在这篇评论中，我们批判性地评估了这种新型阿立哌唑数字配方的潜在有益和有害后果，并强调了对临床实践的预期影响。
相似文献
1
Can a digital medicine system improve adherence to antipsychotic treatment?数字医疗系统能否提高抗精神病药物治疗的依从性？
Epidemiol Psychiatr Sci. 2018 Jun;27(3):227-229. doi: 10.1017/S2045796018000082. Epub 2018 Mar 12.
2
Aripiprazole Lauroxil Long-Acting Injectable: The Latest Addition to Second-Generation Long-Acting Agents.阿立哌唑劳罗西长效注射剂：第二代长效制剂的最新成员。
Clin Schizophr Relat Psychoses. 2016 spring;10(1):58-63. doi: 10.3371/csrp.AGGA.040316.
3
Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.阿立哌唑：其在精神分裂症和分裂情感性障碍中的应用综述
Drugs. 2004;64(15):1715-36. doi: 10.2165/00003495-200464150-00010.
4
Digital aripiprazole or digital evergreening? A systematic review of the evidence and its dissemination in the scientific literature and in the media.数字阿立哌唑还是数字常青？对证据及其在科学文献和媒体中的传播的系统评价。
BMJ Evid Based Med. 2019 Dec;24(6):231-238. doi: 10.1136/bmjebm-2019-111204. Epub 2019 Jul 18.
5
Psychosis patients' knowledge, adherence and attitudes towards the naming of antipsychotic medication in Hong Kong.香港精神病患者对抗精神病药物命名的认知、依从性及态度。
Early Interv Psychiatry. 2015 Oct;9(5):422-7. doi: 10.1111/eip.12169. Epub 2014 Sep 20.
6
Using antipsychotic agents in older patients.在老年患者中使用抗精神病药物。
J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4.
7
The incidence, psychiatric co-morbidity and pharmacological treatment of severe mental disorders in children and adolescents.儿童和青少年严重精神障碍的发病率、精神共病和药物治疗。
Eur Psychiatry. 2018 Mar;49:16-22. doi: 10.1016/j.eurpsy.2017.12.009. Epub 2018 Feb 3.
8
Clinical experience with aripiprazole treatment in ten elderly patients with schizophrenia or schizoaffective disorder: retrospective case studies.
CNS Spectr. 2004 Nov;9(11):862-7. doi: 10.1017/s1092852900002273.
9
Adherence to antipsychotic and nonpsychiatric medications in middle-aged and older patients with psychotic disorders.中年及老年精神病性障碍患者对抗精神病药物和非精神科药物的依从性。
Psychosom Med. 2003 Jan-Feb;65(1):156-62. doi: 10.1097/01.psy.0000040951.22044.59.
10
A cross-sectional observational study of healthcare professional views of factors affecting teenage adherence with antipsychotic medication.一项关于医疗保健专业人员对影响青少年抗精神病药物依从性因素看法的横断面观察性研究。
J Psychiatr Ment Health Nurs. 2015 Sep;22(7):491-501. doi: 10.1111/jpm.12210. Epub 2015 May 20.
引用本文的文献
1
Digital health interventions to improve adherence to oral antipsychotics among patients with schizophrenia: a scoping review.数字健康干预措施改善精神分裂症患者口服抗精神病药物的依从性：范围综述。
BMJ Open. 2023 Nov 17;13(11):e071984. doi: 10.1136/bmjopen-2023-071984.
2
Considering patient perspectives in economic evaluations of health interventions.考虑健康干预措施的经济评估中的患者视角。
Front Public Health. 2023 Oct 9;11:1212583. doi: 10.3389/fpubh.2023.1212583. eCollection 2023.
3
Use of an Ingestible, Sensor-Based Digital Adherence System to Strengthen the Therapeutic Relationship in Serious Mental Illness.使用一种可摄入的、基于传感器的数字依从性系统来加强严重精神疾病中的治疗关系。
JMIR Ment Health. 2022 Dec 2;9(12):e39047. doi: 10.2196/39047.
4
Development of the PREMIUM Computerized Adaptive Testing for Measuring the Quality of Information Delivered to Patients with Severe Mental Illnesses.用于测量提供给重度精神疾病患者的信息质量的PREMIUM计算机自适应测试的开发。
J Clin Med. 2022 Nov 11;11(22):6687. doi: 10.3390/jcm11226687.
5
Calibration and Validation of a PREMIUM-DT Item Bank to Measure the Experience of Drug Therapy for Patients with Severe Mental Illness.用于测量重症精神疾病患者药物治疗体验的PREMIUM-DT题库的校准与验证
J Clin Med. 2022 Jul 22;11(15):4278. doi: 10.3390/jcm11154278.
6
Digital pills: a scoping review of the empirical literature and analysis of the ethical aspects.数字药丸：实证文献的范围综述及伦理方面的分析。
BMC Med Ethics. 2020 Jan 8;21(1):3. doi: 10.1186/s12910-019-0443-1.
本文引用的文献
1
A multicenter, open-label, pilot study evaluating the functionality of an integrated call center for a digital medicine system to optimize monitoring of adherence to oral aripiprazole in adult patients with serious mental illness.一项多中心、开放标签的试点研究，评估数字医学系统综合呼叫中心的功能，以优化对患有严重精神疾病的成年患者口服阿立哌唑依从性的监测。
Neuropsychiatr Dis Treat. 2017 Oct 19;13:2641-2651. doi: 10.2147/NDT.S143091. eCollection 2017.
2
Effectiveness of Digital Medicines to Improve Clinical Outcomes in Patients with Uncontrolled Hypertension and Type 2 Diabetes: Prospective, Open-Label, Cluster-Randomized Pilot Clinical Trial.数字药物改善血压控制不佳的高血压患者和2型糖尿病患者临床结局的有效性：前瞻性、开放标签、整群随机试验性临床试验
J Med Internet Res. 2017 Jul 11;19(7):e246. doi: 10.2196/jmir.7833.
3
Usability of a novel digital medicine system in adults with schizophrenia treated with sensor-embedded tablets of aripiprazole.一种新型数字药物系统在使用含阿立哌唑传感器片剂治疗的成年精神分裂症患者中的可用性。
Neuropsychiatr Dis Treat. 2016 Oct 11;12:2587-2594. doi: 10.2147/NDT.S116029. eCollection 2016.
4
Interventions for enhancing medication adherence.提高药物依从性的干预措施。
Cochrane Database Syst Rev. 2014 Nov 20;2014(11):CD000011. doi: 10.1002/14651858.CD000011.pub4.
5
A qualitative study of the attitudes of patients in an early intervention service towards antipsychotic long-acting injections.一项关于早期干预服务中患者对抗精神病长效注射态度的定性研究。
Ther Adv Psychopharmacol. 2014 Oct;4(5):179-85. doi: 10.1177/2045125314542098.
6
Patients' and clinicians' attitude towards long-acting depot antipsychotics in subjects with a first episode of psychosis.首发精神病患者长效 depot 抗精神病药治疗的患者和临床医生的态度。
Ther Adv Psychopharmacol. 2013 Apr;3(2):89-99. doi: 10.1177/2045125312464106.
7
First experience with a wireless system incorporating physiologic assessments and direct confirmation of digital tablet ingestions in ambulatory patients with schizophrenia or bipolar disorder.在伴有精神分裂症或双相情感障碍的门诊患者中，采用整合生理评估和直接确认数字药片摄入的无线系统的首次应用经验。
J Clin Psychiatry. 2013 Jun;74(6):e533-40. doi: 10.4088/JCP.12m08222.
8
A prospective 3-year longitudinal study of cognitive predictors of relapse in first-episode schizophrenic patients.一项针对首发精神分裂症患者复发认知预测因素的前瞻性3年纵向研究。
Schizophr Res. 2005 Sep 1;77(1):99-104. doi: 10.1016/j.schres.2005.02.020.
9
Overview of partial compliance.部分合规概述。
J Clin Psychiatry. 2003;64 Suppl 16:3-9.
Zotero 插件